Harmony Biosciences Holdings (HRMY) — Long-term Investment Intensity
Harmony Biosciences Holdings (HRMY) has a Long-term Investment Intensity of 8.8% as of September 2025. Long-term investments of $105.83 Million represent 8.8% of total assets of $1.21 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Harmony Biosciences Holdings net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Harmony Biosciences Holdings Long-term Investment Intensity (2022–2024)
This chart shows how Harmony Biosciences Holdings's Long-term Investment Intensity has evolved across 3 annual periods from 2022 to 2024. As of September 2025, the intensity stands at 8.8%, reflecting long-term investments of $105.83 Million against total assets of $1.21 Billion USD. Also explore Harmony Biosciences Holdings asset portfolio for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Harmony Biosciences Holdings (2022–2024)
The table below presents the year-by-year Long-term Investment Intensity for Harmony Biosciences Holdings from 2022 to 2024, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see HRMY stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 10.9% | $108.87 Million | $999.20 Million | ▲ +2.0 pp |
| 2023 | 8.9% | $72.17 Million | $811.45 Million | ▲ +5.5 pp |
| 2022 | 3.3% | $22.57 Million | $673.87 Million | — |